PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma - Concepedia

Concepedia

Publication | Closed Access

PI3K inhibitor impairs tumor progression and enhances sensitivity to anlotinib in anlotinib-resistant osteosarcoma

43

Citations

35

References

2022

Year

Chenglong Chen, Yu Guo, Qingshan Huang, Boyang Wang, Wei Wang, Jianfang Niu, Jingbing Lou, Jiuhui Xu, Tingting Ren, Yi Huang,

OncologyMedicineAnlotinib-resistant OsteosarcomaPathologyAnti-cancer AgentTumor SuppressorCancer TreatmentPharmacologyEnhances SensitivityTumor Biology

References

	Year	Citations

Page 1

Page 1